p.112 抽出テキスト

10809492 300. Hisamatsu K, Morita H, Fukushima Kusano K, et al. Evaluation of the usefulness of recording the ECG in the 3rd intercostal space and prevalence of Brugada-type ECG in accordance with recently established electrocardiographic criteria. Circ J 2004; 68: 135-138. PMID: 14745148 301. Miyamoto K, Yokokawa M, Tanaka K, et al. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2007; 99: 53-57. PMID: 17196462 302. Mizusawa Y, Morita H, Adler A, et al. Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm 2016; 13: 1515- 1520. PMID: 27033637 303. Makimoto H, Nakagawa E, Takaki H, et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010; 56: 1576-1584. PMID: 21029874 304. Takase B, Ikeda T, Shimizu W, et al. Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group. JCS/ JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia. J Arrhythm 2024; 40: 655-752. PMID: 39139890 305. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1320-1329. PMID: 11196553 306. Fujiki A, Usui M, Nagasawa H, et al. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10: 214-218. PMID: 10090224 307. Moore BM, Chan D, Davies B, et al. Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome. Circulation 2026; 153: 154-163. PMID: 41342099 308. Obeyesekere MN, Klein GJ, Modi S, et al. How to perform and interpret provocative testing for the diagnosis of Brugada syndrome, long-QT syndrome, and catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol 2011; 4: 958-964. PMID: 22203660 309. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101: 510-515. PMID: 10662748 310. Morita H, Morita ST, Nagase S, et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003; 42: 1624-1631. PMID: 14607450 311. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070. PMID: 8609322 312. Wilde AAM, Amin AS, Morita H, et al. Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome. Eur Heart J 2023; 44: 2427-2439. PMID: 37345279 313. Morita H, Asada ST, Miyamoto M, et al. Significance of Exercise- Related Ventricular Arrhythmias in Patients With Brugada Syndrome. J Am Heart Assoc 2020; 9: e016907. PMID: 33222599 314. Chakraborty P, Rahimi M, Suszko AM, et al. Exercise-Induced QRS Prolongation in Brugada Syndrome: Implications for Improving Disease Phenotyping and Diagnosis. JACC Clin Electrophysiol 2024; 10: 1813-1824. PMID: 38934974 315. Hofman N, Tan HL, Alders M, et al. Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment? J Am Coll Cardiol 2010; 55: 2570-2576. PMID: 20513597 316. Vohra J, Rajagopalan S. CSANZ Genetics Council Writing Group. Update on the Diagnosis and Management of Brugada Syndrome. Heart Lung Circ 2015; 24: 1141-1148. PMID: 26412486 317. Baranchuk A, Nguyen T, Ryu MH, et al. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol 2012; 17: 299-314. PMID: 23094876 318. Gottschalk BH, Anselm DD, Brugada J, et al. Expert cardiologists cannot distinguish between Brugada phenocopy and Brugada syndrome electrocardiogram patterns. Europace 2016; 18: 1095- 1100. PMID: 26498159 319. Monasky MM, Micaglio E, Locati ET, et al. Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification. Front Cardiovasc Med 2021; 8: 652027. PMID: 33969014 320. Campuzano O, Sarquella-Brugada G, Fernandez-Falgueras A, et al. Genetic interpretation and clinical translation of minor genes related to Brugada syndrome. Hum Mutat 2019; 40: 749-764. PMID: 30821013 321. Milman A, Andorin A, Postema PG, et al. Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome. Heart Rhythm 2019; 16: 1468-1474. PMID: 31284050 322. Nishii N, Ogawa M, Morita H, et al. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome. Circ J 2010; 74: 2572-2578. PMID: 21048329 323. Sommariva E, Pappone C, Martinelli Boneschi F, et al. Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification. Eur J Hum Genet 2013; 21: 911-917. PMID: 23321620 324. Ciconte G, Monasky MM, Santinelli V, et al. Brugada syndrome genetics is associated with phenotype severity. Eur Heart J 2021; 42: 1082-1090. PMID: 33221895 325. Chen C, Tan Z, Zhu W, et al. Brugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis: A meta-analysis. Clin Genet 2020; 97: 198-208. PMID: 30963536 326. Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002; 40: 350-356. PMID: 12106943 327. Hong K, Brugada J, Oliva A, et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004; 110: 3023-3027. PMID: 15520322 328. Yokokawa M, Noda T, Okamura H, et al. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 2007; 100: 649-655. PMID: 17697823 329. Rivaud MR, Delmar M, Remme CA. Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms. Cardiovasc Res 2020; 116: 1557-1570. PMID: 32251506 330. Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 2001; 409: 1043-1047. PMID: 11234013 331. Makiyama T, Akao M, Tsuji K, et al. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 2005; 46: 2100-2106. PMID: 16325048 332. Takehara N, Makita N, Kawabe J, et al. A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J Intern Med 2004; 255: 137-142. PMID: 14687250 333. Makiyama T, Akao M, Shizuta S, et al. A novel SCN5A gain-offunction mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol 2008; 52: 1326-1334. PMID: 18929244 334. Watanabe H, Nogami A, Ohkubo K, et al. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol 2011; 4: 874-881. PMID: 22028457 335. McNair WP, Ku L, Taylor MR, et al. Familial Cardiomyopathy Registry Research Group. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110: 2163-2167. PMID: 15466643 336. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001; 286: 2264-2269. PMID: 11710892 337. Probst V, Allouis M, Sacher F, et al. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 2006; 17: 270-275. PMID: 16643399 338. Smits JP, Koopmann TT, Wilders R, et al. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 2005; 38: 969-981. PMID: 15910881 339. Crotti L, Marcou CA, Tester DJ, et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol 2012; 60: 1410-1418. PMID: 22840528 340. Ghouse J, Have CT, Skov MW, et al. Numerous Brugada syndrome-associated genetic variants have no effect on J-point elevation, syncope susceptibility, malignant cardiac arrhythmia, and all-cause mortality. Genet Med 2017; 19: 521-528. PMID: 27711072 341. Behr ER, Ben-Haim Y, Ackerman MJ, et al. Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a